ArticleCureus2026
Unplanned Readmissions Due to Post-acute Myocardial Infarction Complications: Insights From the Nationwide Readmission Database (2016-2020).
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Acute myocardial infarction (MI) readmissions within 30 days (30-dr) are affecting patient outcomes and healthcare costs. This study analyzed trends in 30-dr for patients discharged after an acute MI. Methods We analyzed the 2016-2020 Nationwide Readmission Database for patients aged 18 years or older with an initial admission for acute MI who were readmitted within 30 days. Variables were identified using ICD-10 codes. The primary outcome was trends in 30-dr; secondary outcomes included trends in complications, mortality, length of stay (LOS), and healthcare costs. Multivariate and descriptive bivariate analyses were conducted, with p-values <0.05 considered statistically significant. Results Among 2,572,790 acute MI index admissions, 221,910 (8.6%) were readmitted within 30 days, with a significant decline in readmission risk over the study period (p < 0.001). Mean age was 66.9 ± 13.5 years. In-hospital mortality decreased over time (OR 0.92, 95% CI 0.88-0.96; p trend < 0.01). During index admissions, vasopressor use and acute kidney injury increased, while periprocedural bleeding declined (OR 0.38, 95% CI 0.33-0.43). In multivariable Cox regression, 30-day readmission risk declined from 2017 to 2019 (HR 0.93 to 0.87) with a slight increase in 2020 (HR 0.94). Higher age (HR 1.01) and comorbidity burden (HR 1.07) were associated with increased risk, while male sex was protective (HR 0.92 [0.90-0.94]). Periprocedural circulatory complications (OR 0.30, 95% CI 0.17-0.51) and bleeding (OR as low as 0.07, 95% CI 0.03-0.17) declined, while post-procedural anemia (OR 1.16, 95% CI 1.06-1.26) and non-inflammatory pericardial effusion (OR 1.62, 95% CI 1.34-1.97) increased. Conclusion 30-dr after acute MI declined over time, but remains driven by increasing comorbidity burden and evolving procedural complication profiles, underscoring the need for targeted risk stratification and post-discharge care. This study highlights relevant data to inform targeted interventions to reduce readmissions and complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.